Englewood Lab Inc (950140) — Capital Reinvestment Ratio
Latest as of September 2025:
0.38x
Englewood Lab Inc (950140) has a Capital Reinvestment Ratio of 0.38x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩6.76 Billion) in capital expenditures (₩2.60 Billion). See 950140 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.38x
Capex / Operating Cash Flow
Operating Cash Flow
₩6.76 Billion
KRW
Capital Expenditures
₩2.60 Billion
KRW
Data as of
Sep 2025
Most recent filing
Englewood Lab Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks Englewood Lab Inc's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Englewood Lab Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for Englewood Lab Inc from 2019 to 2024. For live market cap and broader valuation context, see Englewood Lab Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.39x | ₩9.47 Million | ₩3.70 Million | ▲ +210.2% |
| 2023 | 0.13x | ₩16.01 Million | ₩2.02 Million | ▼ -70.6% |
| 2022 | 0.43x | ₩9.56 Billion | ₩4.10 Billion | ▼ -21.3% |
| 2020 | 0.54x | ₩7.30 Billion | ₩3.98 Billion | ▲ +34.8% |
| 2019 | 0.40x | ₩12.12 Billion | ₩4.90 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow